Our photosensitizers for Theralase anti-cancer photodynamic therapy nears human trials!
The latest research on Photo Dynamic Compound (PDC) technology from Theralase Technologies, proven effective in the destruction of bacteria and cancer, was peer reviewed and invited to be published in Coordination Chemistry Reviews as the company prepares for human clinical trials.
Read more … Our photosensitizers for Theralase anti-cancer photodynamic therapy nears human trials!
Theralase Anti-Cancer Technology Validated in Prestigious US Chemistry Publication
Theralase Technologies Inc. announced today that its latest research on Photo Dynamic Compound (PDC) technology, proven effective in the destruction of bacteria and cancer, was peer reviewed and invited to be published in the prestigious US Elsevier publication, Coordination Chemistry Reviews.
Read more … Theralase Anti-Cancer Technology Validated in Prestigious US Chemistry Publication
ChemCon 2014
Charlotte Fuller, Jordan Gibson, Marc Hetu, and Mitch Pinto receive awards at Science Atlantic ChemCon 2014!
Abstract-A-Palooza 2014
Tariq and Huimin represent the McFarland Labs at Abstract-A-Palooza 2014.
Congrats to this year's graduates!
Congrats to Marc Hetu, Mat Stephenson, and Jordan Gibson on their graduation.